当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-07-19 , DOI: 10.1111/apt.16524 Jill Koshiol, Ilona Argirion, Zhiwei Liu, Tram Kim Lam, Thomas R. O’Brien, Kelly Yu, Katherine A. McGlynn, Jessica L. Petrick, Ligia Pinto, Chien-jen Chen, Allan Hildesheim, Ruth M. Pfeiffer, Mei-Hsuan Lee, Hwai-I Yang
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-07-19 , DOI: 10.1111/apt.16524 Jill Koshiol, Ilona Argirion, Zhiwei Liu, Tram Kim Lam, Thomas R. O’Brien, Kelly Yu, Katherine A. McGlynn, Jessica L. Petrick, Ligia Pinto, Chien-jen Chen, Allan Hildesheim, Ruth M. Pfeiffer, Mei-Hsuan Lee, Hwai-I Yang
|
Clinical and experimental studies suggest immunologic proteins contribute to hepatocellular carcinoma (HCC) development.
中文翻译：
乙型肝炎病毒和丙型肝炎病毒感染者的免疫标志物和肝细胞癌风险
临床和实验研究表明免疫蛋白有助于肝细胞癌 (HCC) 的发展。
更新日期：2021-08-24
中文翻译：
乙型肝炎病毒和丙型肝炎病毒感染者的免疫标志物和肝细胞癌风险
临床和实验研究表明免疫蛋白有助于肝细胞癌 (HCC) 的发展。
京公网安备 11010802027423号